Abstract:
ObjectiveTo investigate the mechanism of Periostin (POSTN) regulating AKT signaling pathway to activate the epithelial-mesenchymal transition (EMT) of gastric cancer cells.
MethodsPericancerous, cancerous, metastases and primary tumor tissues of patients with gastric cancer at different pathological stage were selected for immunofluorescence staining with POSTN and CD44.POSTN gene was overexpressed or knocked out in human gastric cancer cells MGC 803, and AKT inhibitor LY294002 was added for culture.The expression levels of POSTN, CD44 and EMT-related genes in gastric cancer cells were detected using RT-qPCR and Western blotting.The proliferation level of gastric cancer cells was detected using CCK-8.Transwell assays were used to detect the migration and invasion of cells.
ResultsThe expression of POSTN in metastasis was higher than that of primary tumor, and the expression of POSTN in primary tumor was higher than that of pericancerous tissue.Compared with normal MGC 803 cells, the expressions of POSTN, CD44, α-sma, snail, slug, Vimentin were increased and E-Cadherin was reduced in gastric cancer cells overexpressing POSTN, while POSTN knockout inhibited the expressions of CD44, α-sma, snail, slug, Vimentin and increased the expressions of E-Cadherin.The overexpression of POSTN promoted the metastasis and invasion of gastric cancer cells, while the reduction of POSTN inhibited the metastasis and invasion of gastric cancer cells.The addition of LY294002 significantly improved the expression changes of α-sma, snail, slug, Vimentin, E-Cadherin, proliferation activity, migration and invasion ability caused by overexpression of POSTN gene in gastric cancer cells(P < 0.01).
ConclusionsThe expression of POSTN in the cancerous and metastatic of gastric cancer is up-regulated, and the later the clinical stage, the higher the expression of POSTN in the cancerous; POSTN activates the EMT of gastric cancer cells by regulating the AKT signaling pathway, thereby promoting the proliferation, migration and invasion of gastric cancer cells.